hydrochlorothiazide has been researched along with Compensatory Hyperinsulinemia in 7 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neonatal hypoglycemia is one of the most common biochemical abnormalities encountered in the newborn." | 2.50 | Update on neonatal hypoglycemia. ( Rozance, PJ, 2014) |
| "Insulin resistance is associated with a number of risk factors for atherosclerosis, including glucose intolerance, hypertension, and dyslipidemia." | 2.38 | Insulin resistance. An often unrecognized problem accompanying chronic medical disorders. ( Bell, DS, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thus, KA | 1 |
| den Boogert, WJ | 1 |
| van der Heyden, JC | 1 |
| Rozance, PJ | 1 |
| Eriksson, JW | 1 |
| Jansson, PA | 1 |
| Carlberg, B | 1 |
| Hägg, A | 1 |
| Kurland, L | 1 |
| Svensson, MK | 1 |
| Ahlström, H | 1 |
| Ström, C | 1 |
| Lönn, L | 1 |
| Ojbrandt, K | 1 |
| Johansson, L | 1 |
| Lind, L | 1 |
| Komers, R | 1 |
| Rogers, S | 1 |
| Oyama, TT | 1 |
| Xu, B | 1 |
| Yang, CL | 1 |
| McCormick, J | 1 |
| Ellison, DH | 1 |
| Bell, DS | 1 |
| Zhao, D | 1 |
| Kane, C | 1 |
| Lindley, KJ | 1 |
| Johnson, PR | 1 |
| James, RF | 1 |
| Milla, PJ | 1 |
| Aynsley-Green, A | 1 |
| Dunne, MJ | 1 |
2 reviews available for hydrochlorothiazide and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Update on neonatal hypoglycemia.
Topics: Biosensing Techniques; Blood Glucose; Developmental Disabilities; Diazoxide; Diuretics; Female; Gluc | 2014 |
Insulin resistance. An often unrecognized problem accompanying chronic medical disorders.
Topics: Acanthosis Nigricans; Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arteri | 1993 |
1 trial available for hydrochlorothiazide and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Compo | 2008 |
4 other studies available for hydrochlorothiazide and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Thrombocytopaenia: a serious side effect of diazoxide.
Topics: Antihypertensive Agents; Child, Preschool; Diazoxide; Drug Therapy, Combination; Epistaxis; Hemateme | 2019 |
Enhanced phosphorylation of Na(+)-Cl- co-transporter in experimental metabolic syndrome: role of insulin.
Topics: Animals; Blood Pressure; Cells, Cultured; Chromones; HEK293 Cells; Humans; Hydrochlorothiazide; Hype | 2012 |
[A preliminary study of insulin resistance in essential hypertension, simple obesity and acromegaly].
Topics: Acromegaly; Adult; Blood Glucose; Captopril; Drug Therapy, Combination; Female; Humans; Hydrochlorot | 1993 |
Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin.
Topics: Blood Glucose; Cell Membrane; Diazoxide; Disease Management; Electrophysiology; Glycosyltransferases | 1997 |